The final updated ESMO guideline requests that clinicians strongly encourage their patients with WM to enroll in clinical trials, regardless of disease stage and line of treatment.
Clinicians should aim to follow the recommendations set forth in the ESMO guidelines, which are applicable for use worldwide.
Although hyperviscosity is a presentation of WM and must be urgently treated, chemoimmunotherapy regimens and other therapies are important to stabilize WM.
Learn more about current recommendations from the ESMO guideline.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Emmanuel C. Besa. Fast Five Quiz: Can You Treat Waldenström Macroglobulinemia? - Medscape - Mar 22, 2022.